Large-scale testing (Phase 3)Study completedNCT05505916
What this trial is testing
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 145